Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 13, 2016

Primary Completion Date

May 8, 2017

Study Completion Date

May 19, 2017

Conditions
Complicated Intra-abdominal InfectionsComplicated Appendicitis
Interventions
DRUG

Eravacycline

DRUG

Meropenem

DRUG

Placebo

Trial Locations (54)

Unknown

Los Angeles

Indianapolis

Las Vegas

Somers Point

Cleveland

Columbus

Pleven

Plovdiv

Rousse

Sofia

Varna

Jihlava

Kladno

Kolín

Prague

Tallinn

Tartu

Viljandi

Võru

Batumi

Kutaisi

Tbilisi

Zugdidi

Győr

Kaposvár

Pécs

Veszprém

Daugavpils

Liepāja

Rēzekne

Riga

Kaunas

Klaipėda

Vilnius

Bucharest

Cluj-Napoca

Craiova

Târgu Mureş

Timișoara

Arkhangelsk

Kaluga

Krasnodar

Nizhny Novgorod

Saint Petersburg

Volgograd

Vsevolozhsk

Dnipro

Ivano-Frankivsk

Kharkiv

Kyiv

Lviv

Odesa

Uzhhorod

Vinnytsia

All Listed Sponsors
lead

Tetraphase Pharmaceuticals, Inc

INDUSTRY

NCT02784704 - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections | Biotech Hunter | Biotech Hunter